Dr. Chih-Ho Hong

Dermatologist, Surrey, BC

Dr. Hong is a board certified dermatologist working in Greater Vancouver BC, Canada. He runs a busy office based dermatology clinic with a focus on clinical research. He is a Clinical Assistant Professor in the Department of Dermatology and Skin Sciences and teaches at St. Paul’s Hospital in Vancouver, where he is active staff. Dr. Hong is the past head of the BC Section of Dermatology, the current Economics representative for Dermatology at the BCMA, and is the past chair of the Education Committee of the Canadian Dermatology Association. He is also a past examiner in Dermatology for the Royal College of Physicians of Canada residency qualification examination.

Dr. Hong is currently the Canadian representative to SPIN (The Skin Inflammation and Psoriasis International Network) – spindermatology.org

He is active in clinical practice and dermatology research. His main clinical areas of interest are psoriasis and eczema. He has been an investigator in over 100 trials of treatments in dermatology and has over 30 peer reviewed publications. He has lectured locally, nationally, and internationally on dermatology treatments and has been an invited speaker at international dermatology congresses.

11:25 AM - 11:55 AM Arcutis Open Presentation

Friday NOV 12, 2021

Topical Therapy for Psoriasis: Past, Present and Future


  • Provide an overview of current topical treatment approaches for the management of PsO
  • Discuss the challenges of managing psoriasis across the body using a case-based approach
  • Present and review data on emerging therapeutic topical agents for the treatment of PsO


This 30-minute session led by Dr. Melinda Gooderham and Dr. Chih-ho Hong will discuss the approach to managing psoriasis using today’s topical therapies, provide attendees with a framework for enhancing their understanding of the potential use of new topical therapies for the treatment of psoriasis by discussing emerging data and use patient cases to illustrate the present day challenges for Canadian clinicians in managing psoriasis.

12:45 PM - 1:45 PM LEO Pharma Open Session

Friday NOV 12, 2021

Uncovering: Novel Agents, Key Data, and Patient Confidence in AD

This session is a dynamic and interactive program designed to uncover the clinical benefits of novel AD treatments, reveal key data for efficacy outcomes, and includes an interactive discussion on practical applications.



At the end of this program, participants will be able to:

  1. Define the clinical benefits of novel therapies
  2. Apply key data for effective outcomes with AD patients
  3. Explain to patients the mechanism of effect of AD therapy to support body and emotional confidence
11:10 AM - 11:40 AM Amgen Canada Inc Open Presentation

Saturday NOV 13, 2021

What's new in Hidradenitis Suppurativa: From B cells to Biosimilars

Hidradenitis Suppurativa (HS) is a chronic relapsing inflammatory condition that has a major impact on patient's lives. New discoveries about the pathogenesis of HS continue to inform treatment options for these patients. The number of therapeutic options is increasing and many patients are now benefiting from immunomodulatory therapies. Clinicians need to be up to date with the most recent advancements in HS to provide the best therapeutic options for their patients.


  • Review new findings on the pathogenesis of HS
  • Explore therapeutic options for HS
  • Summarize recent important clinically relevant studies